Trump administration blames foreigners for US’s high drug costsBMJ 2018; 360 doi: https://doi.org/10.1136/bmj.k717 (Published 14 February 2018) Cite this as: BMJ 2018;360:k717
- Owen Dyer
A long awaited white paper from the Trump administration aimed at reducing high drug costs in the US puts much of the blame on foreign “free riding” and threatens action to deliberately drive up drug prices in other developed countries.
The new policy document by the President’s Council of Economic Advisers makes minor tweaks to Medicare reimbursement but also suggests that much of the blame and the solution for high drug prices in the US must be shouldered by foreigners.1
“Limiting under-pricing of drugs in foreign countries” should be a key policy focus for the Trump administration, the document argues. “Meaningful reforms would address the root of the problem: foreign, developed nations, that can afford to pay for novel drugs, free-ride by setting drug prices at …